Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Conant Optical Co (HKSE:02276) has a Total Equity of HK$3,031 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Shanghai Conant Optical Co and its competitors.
Is Shanghai Conant Optical Co's Total Equity too high?
Shanghai Conant Optical Co's current Total Equity is HK$3,031 Mil. Overall, Shanghai Conant Optical Co has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Conant Optical Co's Total Equity compare to ISRG and BDX?
Shanghai Conant Optical Co's Total Equity of HK$3,031 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Shanghai Conant Optical Co and its competitors. Shanghai Conant Optical Co's current Total Equity is HK$3,031 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Conant Optical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Conant Optical Co (HKSE:02276) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$15.68, compared to a current price of HK$38.44 — trading 145.2% above its estimated fair value. The current Total Equity is HK$3,031 Mil. Shanghai Conant Optical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Shanghai Conant Optical Co (HKSE:02276), the current Total Equity is HK$3,031 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Conant Optical Co (HKSE:02276) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Conant Optical Co stock appears to be overvalued.
The current stock price of HK$38.44 is trading 145.2% above its estimated GF Value™ of HK$15.68.
GuruFocus considers Shanghai Conant Optical Co to be Significantly Overvalued.
Key valuation signals for HKSE:02276:
Total Equity: HK$3,031 Mil
GF Value™: HK$15.68 vs. price of HK$38.44 (145.2% above fair value)
No single metric tells the full story. See the HKSE:02276 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 1-42, Lane 83, Hongxiang North Road, 4th Floor, Building 35, Lin-gang Special Area, China (Shanghai) Pilot Free Trade Zone China, Shanghai, CHN
Shanghai Conant Optical Co Ltd is a resin spectacle lens manufacturer in China. The company offers a wide range of resin spectacle lenses to its customers including standardized lenses and customized lenses. The spectacle lenses are also tinted, coated, or cast with various films or coatings for added functionality, such as polarised, photochromic, blue-ray blocking, anti-scratch, anti-reflection, and anti-smudge. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the Americas, Europe, Oceania, Africa, and Asia (except for mainland China). It products include: CR-Freeform; CoMax; AC lens; Gaming Glassed, Antifog Lens; MyoEase; Polycarbonate lens; Photochromic coating lens; SingleVision Finished Lens; and Others.
78GF Score
Get the complete analysis for HKSE:02276
Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02276 has been successfully added to your 
